Population with infertility
Conditions
Interventions
Infection and Vaccination group:N/A
Infection without Vaccination group:N/A
Vaccination without Infection group:N/A
Control group:N/A
Sponsors
Reproductive Medical Center, Shandong University
Eligibility
Sex/Gender
Female
Age
21 Years to 49 Years
Inclusion criteria
Inclusion criteria: Patients who plans to receive PGT treatment in our center from January 2023 to January 2024 will be included. All these patients are invited to fill in the online questionnaire, including questions about whether they have been infected with SARS-CoV-2 in the past, the type of vaccination, the name of the manufacturer, and so on. The vaccination information of SARS-CoV-2 can be queried through (Shandong Electronic Health Pass - Vaccination Query; National Government Affairs Service Platform - SARS-CoV-2 Vaccination Information Query).
Exclusion criteria
Exclusion criteria: The exclusion criteria include providing invalid information about SARS-CoV-2 infection and vaccination; Using donated sperm or oocytes; No oocyte recovery or cycle cancellation before fertilization treatment; Losing follow-up and other situations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Embryonic genetic status; | — |
Secondary
| Measure | Time frame |
|---|---|
| Rate of good-quality embryos;Live birth rate;good birth outcome;risk of maternal and neonatal complications; | — |
Countries
China
Contacts
Public ContactNi Tianxiang
Center for Reproductive Medicine, Shandong University
Outcome results
None listed